Literature DB >> 19935608

CAS: which stent for which lesion.

S Müller-Hülsbeck1, H Preuss, H Elhöft.   

Abstract

Current carotid stent designs and their attributes like scaffolding to reduce plaque prolapses and embolization, flexibility, adaptability and conformability to the vessel vary largely. Knowing that differences in behaviour due to stent design exist, especially due to the open cell design (which show high flexibility and therefore adaptability to the vessel but allows in theory easy particle penetration due to open structure) and closed cell designs (which show low flexibility and therefore low adaptability to the vessel but show high resistance to particle penetration due to closed cell design and high scaffolding), physicians have to be aware of these differences when planning carotid artery stenting procedures. The individual characteristics of each stent device may make it an attractive choice in one circumstance but render it less desirable in other situations; in approximately 75% of all procedures, all types of stents will achieve similar outcomes, making adequate device selection unnecessary; for the remaining quarter, careful preoperative screening is mandatory. The aim of this article was to review different stents with regard to latest designs intended for carotid stenting with regard to topics as mentioned above highlighting latest developments in specific designs especially developed for carotid lesion treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19935608

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  4 in total

1.  Lesion-Related Carotid Angioplasty and Stenting with Closed-Cell Design without Embolic Protection Devices in High-Risk Elderly Patients-Can This Concept Work Out? A Single Center Experience Focusing on Stent Design.

Authors:  Silke Hopf-Jensen; Leonardo Marques; Michael Preiß; Stefan Müller-Hülsbeck
Journal:  Int J Angiol       Date:  2014-12

2.  Mesh-covered (Roadsaver) stent as a new treatment modality for symptomatic or high-risk carotid stenosis.

Authors:  Roman Machnik; Piotr Paluszek; Łukasz Tekieli; Karolina Dzierwa; Damian Maciejewski; Mariusz Trystuła; Andrzej Brzychczy; Krzysztof Banaszkiewicz; Robert Musiał; Piotr Pieniążek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-05-30       Impact factor: 1.426

3.  Prospective multicentre study of carotid artery stenting using the MER™ Stent - the OCEANUS study - 30-day and one-year follow-up results.

Authors:  Piotr Pieniążek; Przemysław Nowakowski; Krzysztof Ziaja; Adam Kobayashi; Wojciech Uchto; Jakub Sulżenko; Roman Machnik; Łukasz Tekieli; Dariusz Stańczyk; Krzysztof Plens; Wojciech Zasada; Artur Dziewierz; Damian Ziaja
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-12-31       Impact factor: 1.426

4.  Asymptomatic Cerebral Emboli Following Carotid Artery Stenting: A Diffusion-Weighted MRI Study

Authors:  Erkan Köklü; Şakir Arslan; Elif Sarıönder Gencer; Nermin Bayar; Çağın Mustafa Üreyen; Zehra Erkal; Ahmet Genç; Ramazan Güven; Oğuz Kaan Kaya; Muhammed Rıdvan Ersoysal
Journal:  Anatol J Cardiol       Date:  2022-04       Impact factor: 1.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.